{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:09:46Z","timestamp":1782727786816,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Differentiation of the cause of left ventricular hypertrophy (LVH) is challenging in cases with co-existing hypertension. CMR offers assessment of diffuse myocardial abnormalities via T1 mapping with extracellular volume fraction (ECV) and macroscopic fibrosis via late gadolinium enhancement imaging (LGE). The goal of the study was to understand if CMR parameters can differentiate hypertensive cardiomyopathy (HC) from cardiac amyloidosis (CA) in patients with hypertension and heart failure, using endomyocardial biopsy (EMB) as the gold standard.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively analyzed patients with hypertension, LVH, and heart failure undergoing EMB due to uncertain diagnosis. CMR parameters including cine, LGE characteristics, T1 mapping, and ECV were analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 34 patients were included (mean age 66.5 \u00b1 10.7 years, 79.4% male). The final EMB-based diagnosis was HC (10, 29%), light chain (AL) CA (7, 21%), and transthyretin (ATTR) CA (17, 50%). There was a significant difference in subendocardial LGE (<jats:italic>p<\/jats:italic>\u2009=\u20090.03) and number of AHA segments with subendocardial LGE (<jats:italic>p<\/jats:italic>\u2009=\u20090.005). The subendocardial LGE pattern was most common in AL-CA (85.7%) and African American with HC (80%). ECV elevation (\u2265\u200929%) was present in all patients with CA (AL-CA: 57.6\u2009\u00b1\u20095.2%, ATTR-CA: 59.1\u2009\u00b1\u200915.3%) and HC (37.3\u2009\u00b1\u20094.5%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Extensive subendocardial LGE pattern is not pathognomonic for CA but might also be present in African American patients with longstanding or poorly controlled HTN. The ECV elevation in HC with HF might be more significant than previously reported with an overlap of ECV values in HC and CA, particularly in younger African American patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s10554-024-03262-0","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T04:01:51Z","timestamp":1729137711000},"page":"2559-2570","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Distinguishing hypertensive cardiomyopathy from cardiac amyloidosis in hypertensive patients with heart failure: a CMR study with histological confirmation"],"prefix":"10.1007","volume":"40","author":[{"given":"Katarzyna Elzbieta","family":"Gil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vien","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanfen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia Y.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Mikrut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Satoskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Kahwash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"issue":"1","key":"3262_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12872-017-0556-8","volume":"17","author":"S Mavrogeni","year":"2017","unstructured":"Mavrogeni S, Katsi V, Vartela V et al (2017) The emerging role of Cardiovascular magnetic resonance in the evaluation of hypertensive heart disease. BMC Cardiovasc Disord 17(1):132","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"3262_CR2","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s11897-020-00481-z","volume":"17","author":"MK Burrage","year":"2020","unstructured":"Burrage MK, Ferreira VM (2020) Cardiovascular magnetic resonance for the differentiation of left ventricular hypertrophy. Curr Heart Fail Rep 17(5):192\u2013204","journal-title":"Curr Heart Fail Rep"},{"issue":"4","key":"3262_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10554-018-1320-6","volume":"34","author":"S Nordin","year":"2018","unstructured":"Nordin S, Dancy L, Moon JC, Sado DM (2018) Clinical applications of multiparametric CMR in left ventricular hypertrophy. Int J Cardiovasc Imaging 34(4):577\u2013585","journal-title":"Int J Cardiovasc Imaging"},{"issue":"2","key":"3262_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5494\/wjh.v5.i2.41","volume":"5","author":"K Kuroda","year":"2015","unstructured":"Kuroda K, Kato TS, Amano A (2015) Hypertensive cardiomyopathy: a clinical approach and literature review. World J Hypertens 5(2):41\u201352","journal-title":"World J Hypertens"},{"key":"3262_CR5","doi-asserted-by":"crossref","unstructured":"Hinojar R, Varma N, Child N et al (2015) T1 mapping in discrimination of hypertrophic phenotypes: Hypertensive Heart Disease and hypertrophic cardiomyopathy: findings from the International T1 Multicenter Cardiovascular magnetic resonance study. Circ Cardiovasc Imaging ;8(12)","DOI":"10.1161\/CIRCIMAGING.115.003285"},{"issue":"4","key":"3262_CR6","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1148\/rg.2020190069","volume":"40","author":"S Oda","year":"2020","unstructured":"Oda S, Kidoh M, Nagayama Y et al (2020) Trends in diagnostic imaging of cardiac amyloidosis: emerging knowledge and concepts. Radiographics 40(4):961\u2013981","journal-title":"Radiographics"},{"issue":"2","key":"3262_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","volume":"7","author":"JN Dungu","year":"2014","unstructured":"Dungu JN, Valencia O, Pinney JH et al (2014) CMR-based differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging 7(2):133\u2013142","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"3262_CR8","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","volume":"51","author":"H Vogelsberg","year":"2008","unstructured":"Vogelsberg H, Mahrholdt H, Deluigi CC et al (2008) Cardiovascular magnetic resonance in clinically suspected Cardiac Amyloidosis: noninvasive imaging compared to Endomyocardial Biopsy. J Am Coll Cardiol 51(10):1022\u20131030","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3262_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/hrt.2005.061911","volume":"92","author":"E Perugini","year":"2006","unstructured":"Perugini E, Rapezzi C, Piva T et al (2006) Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 92(3):343","journal-title":"Heart"},{"issue":"1","key":"3262_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1532-429X-14-28","volume":"14","author":"AM MacEira","year":"2012","unstructured":"MacEira AM, Mohiaddin RH (2012) Cardiovascular magnetic resonance in systemic hypertension. J Cardiovasc Magn Reson 14(1):1\u201317","journal-title":"J Cardiovasc Magn Reson"},{"issue":"3","key":"3262_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jacc.2008.08.064","volume":"53","author":"A Rudolph","year":"2009","unstructured":"Rudolph A, Abdel-Aty H, Bohl S et al (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 53(3):284\u2013291","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"3262_CR12","doi-asserted-by":"publisher","first-page":"A20","DOI":"10.1136\/heartjnl-2017-311399.24","volume":"103","author":"A Martinez-Naharro","year":"2017","unstructured":"Martinez-Naharro A, Treibel TA, Abdel-Gadir A et al (2017) 024\u2005spectrum and significance of CMR findings in cardiac transthyretin amyloidosis. Heart 103(Suppl 1):A20\u2013A21","journal-title":"Heart"},{"issue":"20","key":"3262_CR13","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1136\/heartjnl-2016-309576","volume":"102","author":"JCL Rodrigues","year":"2016","unstructured":"Rodrigues JCL, Amadu AM, Dastidar AG et al (2016) Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes. Heart 102(20):1671\u20131679","journal-title":"Heart"},{"issue":"10","key":"3262_CR14","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/j.jcmg.2018.11.024","volume":"12","author":"U Neisius","year":"2019","unstructured":"Neisius U, El-Rewaidy H, Nakamori S et al (2019) Radiomic Analysis of Myocardial Native T 1 imaging discriminates between Hypertensive Heart Disease and hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 12(10):1946\u20131954","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"3262_CR15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00392-020-01771-1","volume":"110","author":"G Chatzantonis","year":"2021","unstructured":"Chatzantonis G, Bietenbeck M, Elsanhoury A et al (2021) Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study. Clin Res Cardiol 110(4):555\u2013568","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"3262_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","volume":"3","author":"IS Syed","year":"2010","unstructured":"Syed IS, Glockner JF, Feng DL et al (2010) Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 3(2):155\u2013164","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"3262_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12968-020-00607-1","volume":"22","author":"CM Kramer","year":"2020","unstructured":"Kramer CM, Barkhausen J, Bucciarelli-Ducci C, Flamm SD, Kim RJ, Nagel E (2020) Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson 22(1):1\u201318","journal-title":"J Cardiovasc Magn Reson"},{"issue":"5","key":"3262_CR18","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/mrm.25507","volume":"74","author":"R Ahmad","year":"2015","unstructured":"Ahmad R, Xue H, Giri S, Ding Y, Craft J, Simonetti OP (2015) Variable density incoherent spatiotemporal acquisition (VISTA) for highly accelerated cardiac MRI. Magn Reson Med 74(5):1266\u20131278","journal-title":"Magn Reson Med"},{"issue":"6","key":"3262_CR19","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1002\/mrm.22766","volume":"65","author":"Y Ding","year":"2011","unstructured":"Ding Y, Chung YC, Jekic M, Simonetti OP (2011) A new approach to autocalibrated dynamic parallel imaging based on the Karhunen-Loeve transform: KL-TSENSE and KL-TGRAPPA. Magn Reson Med 65(6):1786\u20131792","journal-title":"Magn Reson Med"},{"issue":"1","key":"3262_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mrm.20110","volume":"52","author":"DR Messroghli","year":"2004","unstructured":"Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP (2004) Modified look-locker inversion recovery (MOLLI) for high-resolution T 1 mapping of the heart. Magn Reson Med 52(1):141\u2013146","journal-title":"Magn Reson Med"},{"issue":"12","key":"3262_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.115.002613","volume":"4","author":"EB Schelbert","year":"2015","unstructured":"Schelbert EB, Piehler KM, Zareba KM, Moon JC, Ugander M, Messroghli DR et al (2015) Myocardial fibrosis quantified by Extracellular volume is Associated with subsequent hospitalization for heart failure, death, or both across the Spectrum of Ejection Fraction and Heart failure stage. J Am Heart Assoc 4(12):1\u201314","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"3262_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","volume":"18","author":"P Haaf","year":"2016","unstructured":"Haaf P, Garg P, Messroghli DR, Broadbent DA et al (2016) Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reason 18(1):89","journal-title":"J Cardiovasc Magn Reason"},{"issue":"4","key":"3262_CR23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1161\/hc0402.102975","volume":"105","author":"MD Cerqueira","year":"2002","unstructured":"Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for Tomographic Imaging of the heart. Circulation 105(4):539\u2013542","journal-title":"Circulation"},{"issue":"Suppl 1","key":"3262_CR24","first-page":"1","volume":"12","author":"AS Flett","year":"2010","unstructured":"Flett AS, Hasleton JM, Quarta G et al (2010) The full width half maximum technique is superior for LGE quantification regardless of its aetiology. J Cardiovasc Magn Reson 12(Suppl 1):1\u20134","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"3262_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejrad.2008.03.009","volume":"71","author":"K Andersen","year":"2009","unstructured":"Andersen K, Hennersdorf M, Cohnen M et al (2009) Myocardial delayed contrast enhancement in patients with arterial hypertension: initial results of cardiac MRI. Eur J Radiol 71(1):75\u201381","journal-title":"Eur J Radiol"},{"key":"3262_CR26","doi-asserted-by":"publisher","first-page":"H912","DOI":"10.1152\/ajpheart.00494.2020","volume":"320","author":"EKS Espe","year":"2021","unstructured":"Espe EKS, Bendiksen BA, Zhang L, Sjaastad I (2021) Analysis of right ventricular mass from magnetic resonance imaging data: a simple post-processing algorithm for correction of partial-volume effects. Am J Physiol Heart Circ Physiol 320:H912\u2013H922","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"3262_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1046\/j.1523-1755.2002.00420.x","volume":"62","author":"C Marcantoni","year":"2002","unstructured":"Marcantoni C, Ma LJ, Federspiel C, Fogo AB (2002) Hypertensive nephrosclerosis in African americans versus caucasians. Kidney Int 62(1):172\u2013180","journal-title":"Kidney Int"},{"issue":"3","key":"3262_CR28","first-page":"166","volume":"5","author":"WJ Paulus","year":"2017","unstructured":"Paulus WJ, Waddingham MT (2017) Racial tension in Hypertension Divergent effects of African and European Ancestry on Cardiac Remodeling. J Am Coll Cardiol HF 5(3):166\u2013168","journal-title":"J Am Coll Cardiol HF"},{"key":"3262_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jchf.2016.10.011","volume":"5","author":"MM Fernandes-Silva","year":"2017","unstructured":"Fernandes-Silva MM, Shah AM, Hegde S et al (2017) Race-related differences in left ventricular structural and functional remodeling in response to increased afterload: the ARIC Study. JACC Heart Fail 5:157\u2013165","journal-title":"JACC Heart Fail"},{"key":"3262_CR30","doi-asserted-by":"crossref","unstructured":"Brahmbhatt T, Hari P, Cinquegrani M et al (2008) Delayed enhancement on cardiac MRI in a patient with multiple myeloma without amyloidosis. Br J Radiol ;81(971)","DOI":"10.1259\/bjr\/58586915"},{"issue":"3","key":"3262_CR31","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1001\/archinte.1988.00380030168027","volume":"148","author":"PA Pellikka","year":"1988","unstructured":"Pellikka PA, Holmes DR, Edwards WD et al (1988) Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement. Arch Intern Med 148(3):662\u2013666","journal-title":"Arch Intern Med"},{"key":"3262_CR32","doi-asserted-by":"crossref","unstructured":"Rajiah P, Fulton NL, Bolen M (2019) Magnetic resonance imaging of the papillary muscles of the left ventricle: normal anatomy, variants, and abnormalities. Insights Imaging ;10(1)","DOI":"10.1186\/s13244-019-0761-3"},{"key":"3262_CR33","doi-asserted-by":"crossref","unstructured":"Han Y, Peters DC, Salton CJ et al (2008) Cardiovascular magnetic resonance characterization of mitral valve prolapse. JACC Cardiovasc Imaging ;1(3)","DOI":"10.1016\/j.jcmg.2008.01.013"},{"issue":"3","key":"3262_CR34","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1148\/radiol.12112721","volume":"265","author":"CT Sibley","year":"2012","unstructured":"Sibley CT, Noureldin RA, Gai N, Nacif MS, Liu S, Turkbey EB et al (2012) T1 mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology 265(3):724\u2013732","journal-title":"Radiology"},{"issue":"19","key":"3262_CR35","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1136\/heartjnl-2012-302346","volume":"98","author":"DM Sado","year":"2012","unstructured":"Sado DM, Flett AS, Banypersad SM et al (2012) Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 98(19):1436\u20131441","journal-title":"Heart"},{"key":"3262_CR36","doi-asserted-by":"crossref","unstructured":"Treibel TA, Zemrak F, Sado DM et al (2015) Extracellular volume quantification in isolated hypertension - changes at the detectable limits? J Cardiovasc Magn Reson ;17(1)","DOI":"10.1186\/s12968-015-0176-3"},{"issue":"6","key":"3262_CR37","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jcmg.2020.08.027","volume":"14","author":"TJ Poterucha","year":"2021","unstructured":"Poterucha TJ, Elias P, Bokhari S, Einstein AJ et al (2021) Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m pyrophosphate: a test in evolution. JACC Cardiovasc Imaging 14(6):1221\u20131231","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"3262_CR38","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0735-1097(22)01418-8","volume":"79","author":"A Yadalam","year":"2022","unstructured":"Yadalam A, Ceballos A, Bigham T et al (2022) False negative Cardiac Scintigraphy in patients withVal122Ile Transthyretin Cardiac Amyloidosis. J Am Coll Cardiol 79(9):427","journal-title":"J Am Coll Cardiol"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-024-03262-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-024-03262-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-024-03262-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T16:12:54Z","timestamp":1733328774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-024-03262-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3262"],"URL":"https:\/\/doi.org\/10.1007\/s10554-024-03262-0","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,17]]},"assertion":[{"value":"30 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}